British Journal of Pharmacology · 1991 · 75 citations · 24 references
MedicinePharmacologyPharmacotherapyNeuropharmacologyPain MedicinePharmacodynamicsAnalgesiaAnalgesic PharmacologyGabaergic PharmacologyAnalgesic EffectsGaba AgonistsGaba AntagonistsGaba-b Receptor PharmacologyGabaergic Pain ModulationHot PlatesPain PharmacologyPharmacological Pain Relief
1. CGP 35348, a new GABAB antagonist, was examined on antinociception induced by (+/-)-baclofen by use of the hot plate and writhing tests in mice and the paw pressure test in rats. CGP 35348 was also studied in mice on (+/-)-baclofen-induced impairment of rota-rod performance. 2. CGP 35348, injected either i.p. (60-100 mg kg-1 in mouse) or intracerebroventricularly (i.c.v.) (0.5-2.5 micrograms per mouse; 25 micrograms per rat) prevented (+/-)-baclofen-induced antinociception. 3. CGP 35348 did not modify oxotremorine- and morphine-induced antinociception in mice and rats. 4. CGP 35348 (2.5 micrograms i.c.v. per mouse) also prevented (+/-)-baclofen-induced impairment of the rota-rod test. 5. Two other GABAB antagonists, phaclofen (50 micrograms i.c.v. per mouse) and 2-OH-saclofen (2.5 micrograms-10 micrograms i.c.v. per mouse) did not modify (+/-)-baclofen-induced antinociception. 7. These results suggest that, at present, CGP 35348 is the only compound able to antagonize (+/-)-baclofen-induced antinociception.
24
A physiological role for GABAB receptors in the central nervous system
P. Dutar, Roger A. Nicoll · Nature · 1988 · 637 citations
Phaclofen: a peripheral and central baclofen antagonist
David I.B. Kerr, Jennifer Ong, Rolf H. Prager et al. · Brain Research · 1987 · 349 citations
CGP 35348: a centrally active blocker of GABAB receptors
Hans-Rudolf Olpe, Göril Karlsson, Mario F. Pozza et al. · European Journal of Pharmacology · 1990 · 309 citations
Medicine, Neuroscience, Pharmacology +16